<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xml:lang="EN" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName ACSJournal-v102.dtd?><?SourceDTD.Version 1.02?><?ConverterInfo.XSLTName acs2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">ACS Omega</journal-id><journal-id journal-id-type="iso-abbrev">ACS Omega</journal-id><journal-id journal-id-type="publisher-id">ao</journal-id><journal-id journal-id-type="coden">acsodf</journal-id><journal-title-group><journal-title>ACS Omega</journal-title></journal-title-group><issn pub-type="epub">2470-1343</issn><publisher><publisher-name>American Chemical Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7689676</article-id><article-id pub-id-type="doi">10.1021/acsomega.0c02995</article-id><article-categories><subj-group><subject>Article</subject></subj-group></article-categories><title-group><article-title>TLC-MS Bioautography-Based Identification of Free-Radical
Scavenging, &#x003b1;-Amylase, and &#x003b1;-Glucosidase
Inhibitor Compounds of Antidiabetic Tablet BGR-34</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Gaurav</surname><given-names/></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Zahiruddin</surname><given-names>Sultan</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Parveen</surname><given-names>Bushra</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath4"><name><surname>Ibrahim</surname><given-names>Mohammad</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath5"><name><surname>Sharma</surname><given-names>Ikshit</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath6"><name><surname>Sharma</surname><given-names>Sanchit</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath7"><name><surname>Sharma</surname><given-names>Anil Kumar</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath8"><name><surname>Parveen</surname><given-names>Rabea</given-names></name><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath9"><name><surname>Ahmad</surname><given-names>Sayeed</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><aff id="aff1"><label>&#x02020;</label>Bioactive
Natural Product Laboratory, School of Pharmaceutical Education and
Research, <institution>Jamia Hamdard</institution>, New Delhi 110062, <country>India</country></aff><aff id="aff2"><label>&#x02021;</label><institution>AIMIL
Pharmaceuticals (India) Ltd</institution>, Saini Majra, Ropar Nalagarh Rd, Tehsil Nalagarh, Solan District, (H.P) 174101, <country>India</country></aff><aff id="aff3"><label>&#x000a7;</label>Human
Genetics Laboratory, Department of Biosciences, <institution>Jamia Millia Islamia</institution>, New Delhi 110025, <country>India</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Email: <email>sahmad_jh@jamiahamdard.ac.in</email>; <email>sahmad_jh@yahoo.co.in</email>. Phone (Mob): <phone>91-9891374647</phone>. Fax: <fax>00-91-11-26059663</fax>.</corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>11</month><year>2020</year></pub-date><pub-date pub-type="collection"><day>24</day><month>11</month><year>2020</year></pub-date><volume>5</volume><issue>46</issue><fpage>29688</fpage><lpage>29697</lpage><history><date date-type="received"><day>22</day><month>06</month><year>2020</year></date><date date-type="accepted"><day>29</day><month>10</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 American
Chemical Society</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>American Chemical Society</copyright-holder><license><license-p>This is an open access article published under an ACS AuthorChoice <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/page/policy/authorchoice_termsofuse.html">License</ext-link>, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c02995_0005" id="ab-tgr1"/></p><p>BGR-34
is a polyherbal formulation frequently used to combat diabetes
around the globe especially in Asian countries. It provides an attractive
treatment option to prediabetics, diabetics, and in metabolic disorders
by controlling the altered blood glucose level. The lack of phytopharmacological
studies on BGR-34 prompted as to reveal the compounds responsible
for the antidiabetic and free-radical scavenging activity of BGR-34.
An attempt was made to assess <italic>in vitro</italic> &#x003b1;-amylase
and &#x003b1;-glucosidase enzyme inhibition of BGR-34 along with its
free-radical scavenging potential via DPPH scavenging activity. Further,
HPTLC profiling and quantitative analysis of berberine and palmatine
in BGR-34 were carried out. Thereafter, the TLC-bioautographic-MS
analysis was performed to identify the compounds responsible for antidiabetic
and antioxidant activities in BGR-34. The results had shown a significant
and dose-dependent inhibition potential of BGR-34 against <italic>in vitro</italic> &#x003b1;-amylase and &#x003b1;-glucosidase enzymatic
reactions along with significant inhibition in DPPH free-radical scavenging
activity. The HPTLC profiling and quantitative validation studies
showed the presence of berberine and palmatine 44.926 &#x000b1; 0.2907
and 10.507 &#x000b1; 0.154 &#x003bc;g/g, respectively. The TLC-MS bioautography
revealed a total of four DPPH-active, two &#x003b1;-amylase-active,
and nine &#x003b1;-glucosidase-active compounds in BGR-34. It was observed
from the study that BGR-34 possesses verities of bioactive compounds,
which are reasonable not only for its antidiabetic effect but also
for its antioxidant activity.</p></abstract><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>ao0c02995</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>ao0c02995</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><label>1</label><title>Introduction</title><p>Diabetes mellitus is a
chronic metabolic disease characterized
by lacking in production and or utilization of insulin. Hyperglycemia
or increased blood sugar leads to serious damage to many of the body
systems, especially the nerves and blood vessels.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> Type-2 diabetes mellitus (T2DM) characterized due to metabolic
disorders in the endocrine system where insufficient insulin secretion
and its resistance are the basic pathologic characteristics.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> Although &#x003b1;-amylase and &#x003b1;-glucosidase
enzymes play a crucial role as digestive enzymes in hyperglycemia,
the &#x003b1;-amylase enzyme is responsible in breaking down alpha bonds
of alpha-linked polysaccharides, whereas &#x003b1;-glucosidase acknowledged
to control postprandial hyperglycemia. Along with, a simultaneous
therapy as antioxidants, &#x003b1;-amylase, and &#x003b1;-glucosidase
inhibitors provides enough potential to present the onsets of diabetes
and give a reversal therapy to a diabetic patient.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup></p><p>A statistical probable view of World Health Organization
(WHO)
considered that diabetes will be the seventh-leading cause of death
by 2030 and reported about 1.5 million death caused by diabetes in
2012 and which was found more abundant in female than male.<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> As per the 9th edition of the International Diabetes
Federation (IDF 2019) report, diabetes is the fastest-growing health
emergencies of the 21st century, globally. In 2019, IDF is estimated
that 463 million people suffered from diabetes and the number can
be triggered to 578 million by 2030 and 700 million by 2045.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup></p><p>The modern system of medicine deals with
many classes of oral hypoglycemic
drugs, namely, sulfonylureas, biguanides, &#x003b1;-glucosidase inhibitors,
thiazolidinediones, and nonsulfonylureas secretagogues. Despite the
significant progress of these medicines, the results of the treatment
of diabetic patients are still far from perfect. Due to the several
limitations with the use of synthetic antidiabetic drugs, such as
drug resistance, adverse effects, and even toxicity, it prompts the
healthcare researchers for the development of newer and alternative
antidiabetic drugs from natural sources.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup></p><p>In the last few decades, there has been an exponential growth
in
the field of herbal medicines, which are gaining popularity both in
developed and developing countries because of their natural origin,
easy availability and lesser side effects. The analysis of herbal
medicine deals with the long history, especially in the assessment
of the plant&#x02019;s quality and safety. Nevertheless, numerous researches
have been focused on medicinal plant analysis, particularly in the
development of chromatographic and spectroscopic methods. The techniques
are hyphenated with biotools to understand the verities of phytoconstituents
of medicinal plants for the target-based screening of activity. However,
the advancement in technologies provides us with all the steps toward
more formalized analytical and biological investigations.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup></p><p>Thin-layer chromatography (TLC) is one
of the most used, less expensive,
and sophisticated separation techniques and its advancement with high-performance
thin-layer chromatography (HPTLC) based on the full capabilities of
TLC made us far easier in the field of the natural product and phytochemical
analysis. The direct coupling of the compound library or active constituents
separated on the TLC plate with visualizable enzyme reactions can
be used for activity screening, and the assay based on direct screening
of activity-oriented constituents is known as a TLC-bioautography
assay. This technique provides quick access to information concerning
both the localization of the bioactive compounds present in complex
plant matrices and defines their biological activities. Such TLC-based
bioautography through enzymatic reaction provides us the initial stage
to develop activity-based screening of phytochemical constituents
from herbal medicine. The bioautographic analysis coupled with mass
spectroscopy (MS) techniques is purposed to a rapid, high-throughput,
and target-directed isolation and identification of active molecules
based on their enzymatic activity from fractions or multicompound
mixtures.<sup><xref ref-type="bibr" rid="ref8">8</xref></sup></p><p>BGR-34 is an ayurvedic
polyherbal antidiabetic formulation claimed
to be jointly developed by the Council of Scientific &#x00026; Industrial
Research, India (CSIR), National Botanical Research Institute (NBRI),
and Central Institute for Medicinal and Aromatic Plant (CIMAP). The
formulation contains varieties of herbal ingredients like the stem
of Daruharidar (<italic>Berberis aristata</italic>)
and Giloy (<italic>Tinospora cordifolia</italic>), the
heartwood of Vijaysar (<italic>Pterocarpus marsupium</italic>), Gudmar leaves (<italic>Gymnema sylvestre</italic>), Manjeet root (<italic>Rubia cordifolia</italic>),
and Methika seeds (<italic>Trigonella foenumgraecum</italic>). AIMIL Pharmaceuticals (India) Ltd. owns the license for the manufacturing
and marketing of BGR-34 around the globe. Further, the clinical studies
on BGR-34 confirms that it postulates several mechanisms that are
clinically relevant and statistically significant in the reduction
of the three key measures of glucose control such as fasting plasma
glucose (FPG), improved postprandial glucose (PPBG), and hemoglobin
A1c (HbA1c). The trial is registered to the clinical trial registry
of India (CTRI registration number: CTRI/2016/11/007476).<sup><xref ref-type="bibr" rid="ref9">9</xref></sup></p><p>However, until now, many of the preclinical
and clinical studies
have been conducted on BGR-34, but still, there is a lack of research
data that could reveal the bioactive compounds responsible for the
antidiabetic therapeutic potential in BGR-34. Therefore, the present
study is aimed to determine &#x003b1;-amylase, &#x003b1;-glucosidase,
and free-radical scavenging-bioactive compounds that potentiate antidiabetic
and antioxidants activity of BGR-34 through TLC-bioautographic coupled
with MS.</p></sec><sec id="sec2"><label>2</label><title>Results and Discussion</title><p>The extractive
values of different batches of the samples showed
more significant difference, and the percentage yield of the methanolic
extract was obtained as 8.14 &#x000b1; 0.07 for three batches of BGR-34.</p><sec id="sec2.1"><label>2.1</label><title>Total Phenol and Flavonoid Contents</title><p>An average of total
phenolic contents of different batches of BGR-34
was found as 124.5 &#x000b1; 0.34 mg equivalent to GAE/gm extract, whereas
the total flavonoid content was found as 112.12 &#x000b1; 0.36 mg equivalent
to rutin/gm extract, which does not showed statistically significant
differences (<italic>p</italic> &#x0003c; 0.001) in different three batches
of BGR-34. The phenolic and flavonoid content were found higher than
previously reported in a single ingredient of BGR-34.<sup><xref ref-type="bibr" rid="ref10">10</xref>&#x02212;<xref ref-type="bibr" rid="ref14">14</xref></sup></p><p>Further, the result suggests that BGR-34 is enriched with
polyphenols and plays a key role in the management of T2DM by regulating
PPBG, HbA1c, and FPG. The bioactive phytoconstituents regulate the
functional ability of &#x003b1;-glycosidase, DPP-4, and enzymes linked
to the antioxidant defense system and suppress oxidative stress induced
by increased free radicals in T2DM.<sup><xref ref-type="bibr" rid="ref9">9</xref></sup></p><p>Polyphenols are the most abundant antioxidants in medicinal plants
as well as in the daily uses of the human diet. A study cited by Aryaeian
et al. on T2DM cited that phenol and flavonoid exert antioxidant and
antidiabetic activity through enduring the role of the antioxidant
defense system, pancreatic &#x003b2;-cell, and cAMP to function properly.
Besides that, these also regulate phosphodiesterase (PDEs) activity,
which is responsible to suppress &#x003b2;-cell and cAMP function.<sup><xref ref-type="bibr" rid="ref15">15</xref></sup></p><p>Polyphenols are one of the key factors
that play a crucial role
in the management of diabetes by regulating postprandial blood glucose
levels and protection against the deleterious effects of hyperglycemia-induced
oxidative stress. Further, the author claims that the antioxidant
effect of polyphenols enhances insulin sensitivity and catalytic activity
in glucose phosphorylation, which are considered as core alternatives
in the treatment of diabetes mellitus. Polyphenol-rich medicinal herbs/foods
inhibit insulin resistance and pancreatic &#x003b2;-cell damage induced
by oxidative stress (ROS/RSN) resulting in prevention from the progression
of T2DM. Similarly, in our findings, BGR-34 possesses a high content
of phenol and flavonoid, which acts as a factor to exert an antioxidant
and antidiabetic effect.<sup><xref ref-type="bibr" rid="ref16">16</xref></sup></p></sec><sec id="sec2.2"><label>2.2</label><title>DPPH Free-Radical Scavenging Activity</title><p>The varieties
of phytochemicals present in BGR-34 are contributed
to exert antioxidant activity. The free-radical scavenging activity
of different batches of BGR-34 methanolic extract on DPPH radicals
has shown significant and dose-dependent inhibitory potential with
average inhibition of 64.18 &#x000b1; 2.60% at the higher concentration
of 1000 &#x003bc;g/mL with an IC<sub>50</sub> value of 677.69 &#x000b1;
2.29 &#x003bc;g/mL. Ascorbic acid was used as a positive control, which
showed an average inhibition of 99.35 &#x000b1; 1.97% at the concentration
of 1000 &#x003bc;g/mL with an IC<sub>50</sub> value of 80.07 &#x000b1;
2.15 &#x003bc;g/mL. BGR-34 was found to possess statistically significant
antioxidant properties with <italic>p</italic>-value summary** and <italic>p</italic>-value (one-tailed) 0.0043.</p><p>The DPPH assay is the
most used method for the assessment of the antioxidant capacity of
natural products through spectrophotometric techniques based on the
quenching of stable colored radicals. BGR-34 is rich in secondary
metabolites and includes phenol and flavonoid that have antioxidant
activities owing to their redox characteristics. Dietary phenols and
flavonoids have enough ability to scavenge with free radicals induced
by oxidative stress. These polyphenols that strengthen the efficacy
of the antioxidant enzyme defense system have several types of enzymes
such as superoxide dismutase (SOD), glutathione peroxidase (GPx),
glutathione reductase (GR) and catalase (CAT). These enzymes are known
for their pivotal role in suppression of the excessive ROS by breaking
the autoxidative chain reaction, quenching the trace elements, and
preventing the overall cellular injury. Apart from this, maintaining
a normal level of glutathione is important for diabetic patients.
Diabetes induces an alteration in glutathione peroxidase and glutathione
reductase activity, and where diabetic nephropathy is often linked
to low renal glutathione levels.<sup><xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref17">17</xref></sup> The antioxidant
activities of a herbal drug and dietary supplements depend on a large
heterogeneous group of polyphenols and are naturally occurring antioxidants
that play a crucial role in oxidative suppression and cure various
ailments including diabetes (T2DM).<sup><xref ref-type="bibr" rid="ref18">18</xref></sup></p></sec><sec id="sec2.3"><label>2.3</label><title>&#x003b1;-Amylase Inhibitory Potential</title><p>The
&#x003b1;-amylase is a calcium-containing metalloenzyme that breaks
down the &#x003b1;-1,4 linkages of polysaccharide to monosaccharide
in the oral cavity. The imbalanced cellular carbohydrate and lipid
metabolism can cause an increase in the postprandial blood glucose
level, which eventually leads to the onset and progression of T2DM.<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> Therefore, it is important to find natural alternatives
to drugs that can inhibit &#x003b1;-amylase. Amylase-inhibitory potential
of different batches of BGR-34 had shown significant dose-dependent
inhibition with an average inhibition of 88.31% &#x000b1; 2.53 at the
concentration of 1000 &#x003bc;g/mL and an IC<sub>50</sub> value of
45.65 &#x000b1; 1.855 &#x003bc;g/mL, whereas acarbose, which was used as
a positive control, showed a 56.5 &#x000b1; 0.27% inhibition at the concentration
of 1000 &#x003bc;g/mL and an IC<sub>50</sub> value of 775.27 &#x000b1;
3.44 &#x003bc;g/mL. The measurement was taken in triplicate for three
different batches, and average reading is presented. BGR-34 was found
to possess the significant &#x003b1;-amylase inhibitory property with <italic>p</italic>-value summary*** and <italic>p</italic>-value (one-tailed)
0.0006. The average percentage of amylase inhibition of different
samples of BGR-34 at different concentrations (&#x003bc;g/mL) is shown
in <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>. Hence,
the study supports that &#x003b1;-amylase inhibition potential of the
methanolic extract of BGR-34 found more efficient and significant
than acarbose.</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>&#x003b1;-Amylase and &#x003b1;-Glucosidase
Inhibition of BGR-34 Tablet (<italic>n</italic> = 9)</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="char" char="&#x000b1;"/><col align="char" char="&#x000b1;"/></colgroup><thead><tr><th style="border:none;" align="center">&#x000a0;</th><th colspan="2" align="center" char="&#x000b1;">activity
(% inhibition)<hr/></th></tr><tr><th style="border:none;" align="center">concentration (&#x003bc;g/mL)</th><th style="border:none;" align="center" char="&#x000b1;">&#x003b1;-amylase</th><th style="border:none;" align="center" char="&#x000b1;">&#x003b1;-glucosidase</th></tr></thead><tbody><tr><td style="border:none;" align="left">1000</td><td style="border:none;" align="char" char="&#x000b1;">88.31 &#x000b1; 2.53</td><td style="border:none;" align="char" char="&#x000b1;">84.05 &#x000b1; 2.33</td></tr><tr><td style="border:none;" align="left">500</td><td style="border:none;" align="char" char="&#x000b1;">85.27 &#x000b1; 2.77</td><td style="border:none;" align="char" char="&#x000b1;">74.61 &#x000b1; 2.42</td></tr><tr><td style="border:none;" align="left">250</td><td style="border:none;" align="char" char="&#x000b1;">82.85 &#x000b1; 1.95</td><td style="border:none;" align="char" char="&#x000b1;">61.60 &#x000b1;
2.02</td></tr><tr><td style="border:none;" align="left">125</td><td style="border:none;" align="char" char="&#x000b1;">75.75 &#x000b1; 1.97</td><td style="border:none;" align="char" char="&#x000b1;">40.83 &#x000b1; 1.68</td></tr><tr><td style="border:none;" align="left">62.5</td><td style="border:none;" align="char" char="&#x000b1;">61.38 &#x000b1; 2.05</td><td style="border:none;" align="char" char="&#x000b1;">15.96 &#x000b1; 1.48</td></tr><tr><td style="border:none;" align="left">31.25</td><td style="border:none;" align="char" char="&#x000b1;">27.85 &#x000b1; 1.78</td><td style="border:none;" align="char" char="&#x000b1;">12.30 &#x000b1;
0.85</td></tr><tr><td style="border:none;" align="left">15.62</td><td style="border:none;" align="char" char="&#x000b1;">8.81 &#x000b1; 1.65</td><td style="border:none;" align="char" char="&#x000b1;">5.86 &#x000b1; 0.33</td></tr><tr><td style="border:none;" align="left">7.81</td><td style="border:none;" align="char" char="&#x000b1;">1.19 &#x000b1; 0.12</td><td style="border:none;" align="char" char="&#x000b1;">1.52 &#x000b1; 0.40</td></tr></tbody></table></table-wrap><p>Several previous studies demonstrate
that amylase inhibitors, particularly
acarbose (pseudotetrasaccharide), have been used in the treatment
of diabetes where it regulates the modulatory effects of PPG and HbA1c
in hyperglycemia.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> The &#x003b1;-amylase
inhibitors block or slows down the absorption of starch into the gastrointestinal
tract (GIT) mainly by blocking the hydrolysis of 1,4-glycosidic linkages
of starch and other oligosaccharides into maltose and other simple
sugars.<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> Diabetes-induced oxidative stress
occurs as a result of slow progress in the treatment of diabetes due
to the formation of free radicals generated through glucose oxidation
and the subsequent oxidative degradation of glycated proteins in the
body. Therefore, the phenol, flavonoid, and alkaloid compounds are
frequently recommended avoiding such complications.<sup><xref ref-type="bibr" rid="ref22">22</xref></sup></p></sec><sec id="sec2.4"><label>2.4</label><title>&#x003b1;-Glucosidase Inhibitory
Potential</title><p>The &#x003b1;-glucosidase enzyme can significantly
increase the postprandial
blood glucose in type-2 diabetes patients. Therefore, &#x003b1;-glucosidase
inhibitors regulate postprandial hyperglycemia by delaying carbohydrate
absorption.<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> BGR-34 is the most credible
natural and alternative therapy that has an immense potential against
the &#x003b1;-glucosidase activity. The present study was conducted
to evaluate the inhibitory potential of BGR-34 against &#x003b1;-glucosidase
activity. The results show a significant dose-dependent inhibitory
potential with an average inhibition of 84.05 &#x000b1; 2.33% at the
concentration of 1000 &#x003bc;g/mL and an IC<sub>50</sub> of value
136.35 &#x000b1; 2.35 &#x003bc;g/mL, whereas acarbose showed 46.5 &#x000b1;
0.53% inhibition at the concentration of 1000 &#x003bc;g/mL. The mean
values of three different batches (<italic>n</italic> = 9) are presented.
BGR-34 was found to possess the significant &#x003b1;-glucosidase inhibitory
property with <italic>P</italic>-value summary*** and <italic>P</italic>-value (one-tailed) &#x0003c;0.0001. The average percentage of &#x003b1;-glucosidase
inhibition of different samples of BGR-34 at different concentrations
(&#x003bc;g/mL) is shown in <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>. Hence, the study suggests that &#x003b1;-glucosidase
inhibition potential of BGR-34 is more efficient and significant than
acarbose.</p><p>In a recent study conducted on healthy subjects, it
demonstrates that the treatment effect of natural &#x003b1;-glucosidase
inhibitors (acarbose) is not only based on delayed digestion of complex
carbohydrates in the gut but also on the metabolic effects of colonic
starch fermentation.<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> Hence, &#x003b1;-glucosidase
inhibitors may be an effective therapy in the treatment of type-2
diabetes as it specifically targets postprandial hyperglycemia. The
main advantage of &#x003b1;-glucosidase inhibitors is the absence of
any hypoglycemic events or other life-threatening events on overdoses.<sup><xref ref-type="bibr" rid="ref25">25</xref></sup></p></sec><sec id="sec2.5"><label>2.5</label><title>HPTLC Fingerprinting</title><p>Herbal products
contain several verities of secondary metabolites with large chemical
diversity, and it is very difficult to target a particular constituent
concerning their biological activity. In these cases, TLC fingerprint
profiling of herbal products is very useful and widely used for qualitative
and quantitative evaluation. The compounds separated on the TLC plate
at different <italic>R</italic><sub>f</sub> values represent the number
of chemical constituents present in the mixture/extract.<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> Moreover, in HPTLC fingerprinting of BGR-34,
the plate was developed in the defined solvent system <italic>n</italic>-butanol:water:glacial acetic acid (6:3:1, v/v/v) and scanned at
254 and 366 nm before derivatization and at 540 nm post derivatization.
HPTLC chromatographic analysis of different batches of samples showed
9, 7, and 11 prominent spots at different values at 254, 366, and
540 nm, respectively. The chromatographic profiling revealed that
several major and minor constituents present in the methanolic extract
of BGR-34. The constituent intensity was identified according to their
AUC value/peak intensity (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>, <xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>).</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>HPTLC plate view at 366 nm and different chromatograms of BGR-34
at different wavelengths. Panel (a) represents track numbers S1&#x02013;S3
of different three batches of BGR-34, and track numbers A&#x02013;G
are the mixed standard of berberine and palmatine in duplicates at
366 nm. Panels (b)&#x02013;(d) show chromatograms of the sample at
254, 366, and 540 nm, respectively, whereas panel (e) shows chromatogram
of mixed standard at 366 nm.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c02995_0002" id="gr1" position="float"/></fig><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><title>Comparative TLC Profiling of BGR-34
at Different Wavelengths</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">&#x000a0;</th><th colspan="9" align="center">wavelength<hr/></th></tr><tr><th style="border:none;" align="center">&#x000a0;</th><th colspan="3" align="center">254
nm<hr/></th><th colspan="3" align="center">366
nm<hr/></th><th colspan="3" align="center">540
nm<hr/></th></tr><tr><th style="border:none;" align="center"><italic>R</italic><sub>f</sub></th><th style="border:none;" align="center">batch
1</th><th style="border:none;" align="center">batch 2</th><th style="border:none;" align="center">batch 3</th><th style="border:none;" align="center">batch 1</th><th style="border:none;" align="center">batch 2</th><th style="border:none;" align="center">batch 3</th><th style="border:none;" align="center">batch 1</th><th style="border:none;" align="center">batch 2</th><th style="border:none;" align="center">batch 3</th></tr></thead><tbody><tr><td style="border:none;" align="left">0.09</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td></tr><tr><td style="border:none;" align="left">0.19</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td></tr><tr><td style="border:none;" align="left">0.27</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td></tr><tr><td style="border:none;" align="left">0.29</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td></tr><tr><td style="border:none;" align="left">0.33</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td></tr><tr><td style="border:none;" align="left">0.45</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td></tr><tr><td style="border:none;" align="left">0.48</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td></tr><tr><td style="border:none;" align="left">0.56</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td></tr><tr><td style="border:none;" align="left">0.64</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td></tr><tr><td style="border:none;" align="left">0.69</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td></tr><tr><td style="border:none;" align="left">0.75</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td></tr><tr><td style="border:none;" align="left">0.80</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td></tr><tr><td style="border:none;" align="left">0.84</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td></tr><tr><td style="border:none;" align="left">0.88</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td></tr><tr><td style="border:none;" align="left">0.98</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td><td style="border:none;" align="left">+</td></tr><tr><td style="border:none;" align="left">total number of metabolites</td><td style="border:none;" align="left">10</td><td style="border:none;" align="left">10</td><td style="border:none;" align="left">09</td><td style="border:none;" align="left">08</td><td style="border:none;" align="left">08</td><td style="border:none;" align="left">07</td><td style="border:none;" align="left">11</td><td style="border:none;" align="left">11</td><td style="border:none;" align="left">11</td></tr></tbody></table></table-wrap></sec><sec id="sec2.6"><label>2.6</label><title>Quantitative
Estimation of Berberine and Palmatine</title><p>For the quantitative
estimation of berberine and Palmatine, a presample-applied
HPTLC plate was developed in a development chamber containing <italic>n</italic>-butanol:water:glacial acetic acid (6:3:1, v/v/v) as a
solvent system and densitometry scanning was performed at 366 nm.
The developed method for berberine and palmatine was linear, ranging
from 100 to 4000 ng for both with regression coefficient (<italic>r</italic><sup>2</sup>) 0.999 and 0.998, respectively. The limit
of detections (LODs) of the developed method for berberine and palmatine
were 12.0 and 12.7 ng/spot, whereas the limit of quantifications (LOQs)
were 36.3 and 38.4 ng/spot, respectively. The percentage accuracy
values of the developed method for berberine and palmatine were 99.71&#x02013;100.13%
and 99.36&#x02013;100.6%, respectively. The average quantity of berberine
and palmatine in all three batches was found to be 44.926 &#x000b1; 0.2907
and 10.507 &#x000b1; 0.154 &#x003bc;g/g, respectively. The HPTLC plate
and their chromatogram are shown in <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>.</p></sec><sec id="sec2.7"><label>2.7</label><title>TLC-Bioautography Assay</title><p>The TLC-bioautography
assay was performed to screen antioxidant, &#x003b1;-amylase- and &#x003b1;-glucosidase-active
compounds present in BGR-34. After MS analysis, the TLC DPPH-bioautography-active
spots spectral data revealed four free-radical scavenging compounds
as gallic acid (<italic>m/z</italic> = 170.12), quercetin (<italic>m/z</italic> = 302.04), chlorogenic acid (<italic>m/z</italic> =
354.09), and myricetin (<italic>m/z</italic> = 318.03) with <italic>R</italic><sub>f</sub> values of 0.77, 0.74, 0.46, and 0.26, respectively
(<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>, <xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>).</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>TLC-bioautography. Panel
(I) represents DPPH scavenged treated
TLC bioautogram of three different batches of BGR-34 where (I-A,A<sub>1</sub>,A<sub>2</sub>) is showing yellow spots against the dark purple
color background, (I-B,B<sub>1</sub>,B<sub>2</sub>) represents the
normal view (control TLC) of plates before DPPH scavenging, and (I-C,C<sub>1</sub>,C<sub>2</sub>) represents scrapped DPPH active spots from
TLC plates. Panel (II) represents &#x003b1;-amylase-treated TLC bioautogram
of three different batches of BGR-34 where (II-A,A<sub>1</sub>,A<sub>2</sub>) is showing dark blue/violet spots at the brown color background,
(II-B,B<sub>1</sub>,B<sub>2</sub>) represents the normal view (control
TLC) of plates before amylase treatment, and (II-C,C<sub>1</sub>,C<sub>2</sub>) represents scrapped &#x003b1;-amylase active spots from TLC
plates. Panel (III) represents &#x003b1;-glucosidase-treated TLC bioautogram
of three different batches of BGR-34 where (III-A,A<sub>1</sub>,A<sub>2</sub>) is showing white/ceramic spots against the purple color
background, (III-B,B<sub>1</sub>,B<sub>2</sub>) represents the normal
view (control TLC) of plates before &#x003b1;-glucosidase treatment,
and (III-C,C<sub>1</sub>,C<sub>2</sub>) represents scrapped &#x003b1;-glucosidase
active spots from TLC plates.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c02995_0003" id="gr2" position="float"/></fig><table-wrap id="tbl3" position="float"><label>Table 3</label><caption><title>Isolated Bioactive Compounds from
BGR-34 Tablet through TLC-Bioautography-MSm</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="char" char="."/><col align="char" char="."/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">TLC <italic>R</italic><sub>f</sub> value</th><th style="border:none;" align="center">name of
compounds</th><th style="border:none;" align="center" char=".">exact mass</th><th style="border:none;" align="center" char=".">tentative mass</th><th style="border:none;" align="center">molecular
formula</th><th style="border:none;" align="center">mass ID</th><th style="border:none;" align="center">activities</th></tr></thead><tbody><tr><td style="border:none;" align="left">0.77</td><td style="border:none;" align="left">gallic acid</td><td style="border:none;" align="char" char=".">170.12</td><td style="border:none;" align="char" char=".">170.19</td><td style="border:none;" align="left">C<sub>6</sub>H<sub>2</sub>(OH)<sub>3</sub>COOH</td><td style="border:none;" align="left">PubChem CID: 370</td><td rowspan="4" style="border:none;" align="left">antioxidant activity</td></tr><tr><td style="border:none;" align="left">0.74</td><td style="border:none;" align="left">quercetin</td><td style="border:none;" align="char" char=".">302.04</td><td style="border:none;" align="char" char=".">302.10</td><td style="border:none;" align="left">C<sub>15</sub>H<sub>10</sub>O<sub>7</sub></td><td style="border:none;" align="left">MBID-BS003389</td></tr><tr><td style="border:none;" align="left">0.46</td><td style="border:none;" align="left">chlorogenic acid</td><td style="border:none;" align="char" char=".">354.09</td><td style="border:none;" align="char" char=".">354.98</td><td style="border:none;" align="left">C<sub>16</sub>H<sub>18</sub>O<sub>9</sub></td><td style="border:none;" align="left">MBID-PB005541</td></tr><tr><td style="border:none;" align="left">0.26</td><td style="border:none;" align="left">myricitine</td><td style="border:none;" align="char" char=".">318.03</td><td style="border:none;" align="char" char=".">317.16</td><td style="border:none;" align="left">C<sub>15</sub>H<sub>10</sub>O<sub>8</sub></td><td style="border:none;" align="left">MBID BS003379</td></tr><tr><td style="border:none;" align="left">0.65</td><td style="border:none;" align="left">berberine</td><td style="border:none;" align="char" char=".">336.12</td><td style="border:none;" align="char" char=".">336.14</td><td style="border:none;" align="left">C<sub>20</sub>H<sub>18</sub>NO<sub>4</sub>+</td><td style="border:none;" align="left">MBID
TY000105</td><td rowspan="2" style="border:none;" align="left">amylase activity</td></tr><tr><td style="border:none;" align="left">0.56</td><td style="border:none;" align="left">palmatine</td><td style="border:none;" align="char" char=".">352.15</td><td style="border:none;" align="char" char=".">352.33</td><td style="border:none;" align="left">C<sub>21</sub>H<sub>24</sub>NO<sub>4</sub>+</td><td style="border:none;" align="left">MBID TY000051</td></tr><tr><td rowspan="5" style="border:none;" align="left">0.95</td><td style="border:none;" align="left">&#x003b2;-sitosterol</td><td style="border:none;" align="char" char=".">414.70</td><td style="border:none;" align="char" char=".">413.46</td><td style="border:none;" align="left">C<sub>29</sub>H<sub>50</sub>O</td><td style="border:none;" align="left">NISTR: 83&#x02013;46-5</td><td rowspan="9" style="border:none;" align="left">glucosidase activity</td></tr><tr><td style="border:none;" align="left">vanillic acid</td><td style="border:none;" align="char" char=".">168.04</td><td style="border:none;" align="char" char=".">167.22</td><td style="border:none;" align="left">C<sub>8</sub>H<sub>8</sub>O<sub>4</sub></td><td style="border:none;" align="left">MBID BS003123</td></tr><tr><td style="border:none;" align="left">ellagic acid</td><td style="border:none;" align="char" char=".">302.19</td><td style="border:none;" align="char" char=".">301.39</td><td style="border:none;" align="left">C<sub>14</sub>H<sub>6</sub>O<sub>8</sub></td><td style="border:none;" align="left">PCID: 5281855</td></tr><tr><td style="border:none;" align="left">jatrorrhizine</td><td style="border:none;" align="char" char=".">338.38</td><td style="border:none;" align="char" char=".">338.58</td><td style="border:none;" align="left">C<sub>20</sub>H<sub>20</sub>NO<sub>4</sub></td><td style="border:none;" align="left">PCID 72323</td></tr><tr><td style="border:none;" align="left">columbamine</td><td style="border:none;" align="char" char=".">338.38</td><td style="border:none;" align="char" char=".">338.58</td><td style="border:none;" align="left">C<sub>20</sub>H<sub>20</sub>NO<sub>4</sub></td><td style="border:none;" align="left">PCID
72310</td></tr><tr><td rowspan="4" style="border:none;" align="left">0.85</td><td style="border:none;" align="left">kaempferol
7-O-glucoside</td><td style="border:none;" align="char" char=".">448.38</td><td style="border:none;" align="char" char=".">448.18</td><td style="border:none;" align="left">C<sub>21</sub>H<sub>20</sub>O<sub>11</sub></td><td style="border:none;" align="left">PCID 10095180</td></tr><tr><td style="border:none;" align="left">columbin</td><td style="border:none;" align="char" char=".">358.39</td><td style="border:none;" align="char" char=".">359.18</td><td style="border:none;" align="left">C<sub>20</sub>H<sub>22</sub>O<sub>6</sub></td><td style="border:none;" align="left">40</td></tr><tr><td style="border:none;" align="left">isorhamnetin</td><td style="border:none;" align="char" char=".">316.26</td><td style="border:none;" align="char" char=".">317.26</td><td style="border:none;" align="left">C<sub>16</sub>H<sub>12</sub>O<sub>7</sub></td><td style="border:none;" align="left">PCID 5281654</td></tr><tr><td style="border:none;" align="left">cannabisin G</td><td style="border:none;" align="char" char=".">624.69</td><td style="border:none;" align="char" char=".">624.99</td><td style="border:none;" align="left">C<sub>36</sub>H<sub>36</sub>N<sub>2</sub>O<sub>8</sub></td><td style="border:none;" align="left">PCID 10438919</td></tr></tbody></table></table-wrap><p>Although the current shreds
of evidence strongly support gallic
acid, quercetin, chromogenic acid, and myricetin to have excellent
antioxidant potential evaluated through several experimental models,
many authors suggested that bioactive compounds from herbal products
have been used as a nutritional supplement to combat different kinds
of diseases, including diabetes, cardiac disorders, and cancer.<sup><xref ref-type="bibr" rid="ref27">27</xref>&#x02212;<xref ref-type="bibr" rid="ref30">30</xref></sup> The <italic>in vitro</italic> study conducted by Viapiana and Wesolowski
concluded that dietary intake of natural products containing phenolic
and flavonoid such as gallic acid, quercetin, chlorogenic acid, and
myricetin has recently received great attention due to the epidemiological
evidence that correlates a regular intake of these products protects
against several diseases.<sup><xref ref-type="bibr" rid="ref31">31</xref></sup></p><p>Furthermore,
in &#x003b1;-amylase TLC bioautography, the MS analysis
of the scraped bioactive bands from the controlled TLC revealed two
prominent bioactive compounds as berberine (<italic>m/z</italic> =
336.12) and palmatine (<italic>m/z</italic> = 352.15) with <italic>R</italic><sub>f</sub> values of 0.65 and 0.56, respectively (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>, <xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>).</p><p>Berberine and palmatine
are the well-known natural isoquinoline
alkaloidal compounds present in the roots, rhizomes, stem, and bark
of <italic>Berberis aristata</italic> and <italic>Tinospora cordifolia</italic> of BGR-34. The bioautographic
result reveals that berberine and palmatine are the major constituents
of BGR-34, which shows inhibitory potential against &#x003b1;-amylase.
An extensive search in electronic databases revealed their action
to improve insulin resistance and show a reversal effect against hyperglycemia.
The study, cited by Cicero, reported that berberine and palmatine
exert their antidiabetic potential by affecting glucose metabolism,
increasing insulin secretion, stimulating glycolysis, suppressing
adipogenesis, inhibiting mitochondrial function, activating the 5&#x02032;
adenosine monophosphate-activated protein kinase (AMPK) pathway, and
increasing glucokinase activity. The previous studies support that
berberine and palmatine not only inhibit &#x003b1;-amylase activity
in hyperglycemia but also increase the glucose uptake by muscles,
which leads to a reversal effect on hyperglycemia. These isoquinoline
alkaloids also protect the injury of hearts that occurs due to oxidative
and inflammatory stress. The herbal formulation containing berberine
and palmatine is considered as safe due to the low incidence of adverse
reactions, such as gastrointestinal discomfort, and transient increases
in the plasma bilirubin level.<sup><xref ref-type="bibr" rid="ref32">32</xref>&#x02212;<xref ref-type="bibr" rid="ref34">34</xref></sup></p><p>Moreover, in the case of
&#x003b1;-glucosidase TLC-bioautography,
two wide white active zones appeared on TLC-bioautogram. The corresponding
spot from the control plate of both active zones were scrapped, and
MS analysis was performed. Data obtained from MS revealed five compounds
at an <italic>R</italic><sub>f</sub> value of 0.95 including &#x003b2;-sitosterol
(m/<italic>z</italic> = 414.70), vanillic acid (<italic>m/z</italic> = 168.04), ellagic acid (<italic>m/z</italic> = 302.19), jatrorrhizine
(<italic>m/z</italic> = 338.38), and columbamine (<italic>m/z</italic> = 338.38) while four componds at a 0.85 <italic>R</italic><sub>f</sub> value identified as kaempferol 7-O-glucoside (<italic>m/z</italic> = 448.38), columbin (<italic>m/z</italic> = 358.39), isorhamnetin
(<italic>m/z</italic> = 316.26), and cannabisin G (624.69) (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref> and <xref rid="tbl3" ref-type="other">Table <xref rid="tbl3" ref-type="other">3</xref></xref>).</p><p>The inhibition of &#x003b1;-amylase
and &#x003b1;-glucosidase is a
clinical strategy for the management of T2DM, and herbal medicines
have been reported to credibly alleviate hyperglycemia.<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> Previous studies performed on &#x003b2;-sitosterol
support it as established &#x003b1;-glucosidase inhibitors or antidiabetic
compounds present in varieties of herbs and herbal formulations.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> Phenolic compounds such as vanillic acid and
ellagic acid and kaempferol 7-O-glucoside were also detected as &#x003b1;-glucosidase
inhibitors and also considered as a strong candidate for antidiabetic
and antioxidant activity. These compounds lead to strong credentials
of &#x003b1;-glucosidase inhibitors and a natural approach to treat
diabetes.<sup><xref ref-type="bibr" rid="ref37">37</xref>&#x02212;<xref ref-type="bibr" rid="ref39">39</xref></sup> Although Columbine, columbamine, and jatrorrhizine
are the key markers of <italic>Tinospora cordifolia</italic> that possess hypoglycemic potential by lowering the elevated blood
glucose level, which is confirmed by several experimental models.<sup>40&#x02013;</sup><sup><xref ref-type="bibr" rid="ref42">42</xref></sup> Ishaq et al. reported
that flavonoid such as isorhamnetin ameliorates the hyperglycemic
effect through its &#x003b1;-glucosidase inhibitory potential and antioxidative
stress potential also.<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> According to the
report of Subramoniam et al., cannabisin G, a naturally occurring
lignanamide, has an immense effect as an &#x003b1;-glucosidase inhibitor.<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> The reported antioxidants and antidiabetic compounds
with their chemical structure are summarized in <xref rid="tbl4" ref-type="other">Table <xref rid="tbl4" ref-type="other">4</xref></xref> and <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>.</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Systematic diagram represents phytopharmacological evaluation
of
BGR-34. In the study, initially, BGR-34 methanolic extract was processed
to HPTLC fingerprinting at 254 nm, 366 nm before derivatization, and
540 mm post derivatization. Further, BGR-34 proceeded for the identification
of free radical scavenging compounds, &#x003b1;-amylase, and &#x003b2;-glucosidase
inhibitors through the TLC-bioautographic method coupled with mass
spectrometry. Several numbers of phytoconstituents were identified
in the methanolic extract of BGR-34 having anti-oxidant, &#x003b1;-amylase,
and &#x003b2;-glucosidase inhibitory activities. The quantitative validation
of BGR-34 was done using berberine and palmetin as major markers of
BGR-34. As per the research DATA base of BGR-34, its ingredients,
and their phytochemical constituents, it is obliged to many of physiological
action in the body such as decreased glucose production by the liver,
increase GLP-1 and GIP and decrease glucose absorption in the gut,
increase insulin secretion and enhance insulin sensitivity, retard
gastric glucose absorption, increase glucose uptake and storage by
muscle, reduce the feeling of hunger, decrease the chances of diabetic
nephropathy, protect from oxidative damage and control blood glucose
level, and block DPP4 enzyme activity.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c02995_0004" id="gr3" position="float"/></fig><table-wrap id="tbl4" position="float"><label>Table 4</label><caption><title>Reported Antioxidant and Antidiabetic
Compounds Present in BGR-34</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">S.N</th><th style="border:none;" align="center">compound name</th><th style="border:none;" align="center">reported activity</th></tr></thead><tbody><tr><td style="border:none;" align="left">1</td><td style="border:none;" align="left">gallic acid</td><td style="border:none;" align="left">antioxidant
activity<sup><xref ref-type="bibr" rid="ref27">27</xref></sup></td></tr><tr><td style="border:none;" align="left">2</td><td style="border:none;" align="left">quercetin</td><td style="border:none;" align="left">antioxidant activity<sup><xref ref-type="bibr" rid="ref28">28</xref></sup></td></tr><tr><td style="border:none;" align="left">3</td><td style="border:none;" align="left">chlorogenic acid</td><td style="border:none;" align="left">antioxidant activity<sup><xref ref-type="bibr" rid="ref29">29</xref></sup></td></tr><tr><td style="border:none;" align="left">4</td><td style="border:none;" align="left">myricetin</td><td style="border:none;" align="left">antioxidant activity<sup><xref ref-type="bibr" rid="ref30">30</xref></sup></td></tr><tr><td style="border:none;" align="left">5</td><td style="border:none;" align="left">berberine</td><td rowspan="2" style="border:none;" align="left">antidiabetic activity (amylase inhibitor)<sup><xref ref-type="bibr" rid="ref32">32</xref>&#x02212;<xref ref-type="bibr" rid="ref34">34</xref></sup></td></tr><tr><td style="border:none;" align="left">6</td><td style="border:none;" align="left">palmatine</td></tr><tr><td style="border:none;" align="left">7</td><td style="border:none;" align="left">&#x003b2;-sitosterol</td><td style="border:none;" align="left">antidiabetic
activity (glucosidase inhibitor)<sup><xref ref-type="bibr" rid="ref36">36</xref></sup></td></tr><tr><td style="border:none;" align="left">8</td><td style="border:none;" align="left">vanillic acid</td><td style="border:none;" align="left">antidiabetic
activity (glucosidase inhibitor)<sup><xref ref-type="bibr" rid="ref37">37</xref></sup></td></tr><tr><td style="border:none;" align="left">9</td><td style="border:none;" align="left">ellagic acid</td><td style="border:none;" align="left">antidiabetic
activity (glucosidase inhibitor)<sup><xref ref-type="bibr" rid="ref38">38</xref></sup></td></tr><tr><td style="border:none;" align="left">10</td><td style="border:none;" align="left">kaempferol 7-O-glucoside</td><td style="border:none;" align="left">antidiabetic activity (glucosidase inhibitor)<sup><xref ref-type="bibr" rid="ref39">39</xref></sup></td></tr><tr><td style="border:none;" align="left">11</td><td style="border:none;" align="left">columbin</td><td style="border:none;" align="left">antidiabetic activity (glucosidase inhibitor)<sup><xref ref-type="bibr" rid="ref40">40</xref></sup></td></tr><tr><td style="border:none;" align="left">12</td><td style="border:none;" align="left">columbamine</td><td style="border:none;" align="left">antidiabetic activity (glucosidase inhibitor)<sup><xref ref-type="bibr" rid="ref41">41</xref></sup></td></tr><tr><td style="border:none;" align="left">13</td><td style="border:none;" align="left">jatrorrhizine</td><td style="border:none;" align="left">antidiabetic activity (glucosidase inhibitor)<sup><xref ref-type="bibr" rid="ref42">42</xref></sup></td></tr><tr><td style="border:none;" align="left">14</td><td style="border:none;" align="left">isorhamnetin</td><td style="border:none;" align="left">antidiabetic activity (glucosidase inhibitor)<sup><xref ref-type="bibr" rid="ref43">43</xref></sup></td></tr><tr><td style="border:none;" align="left">15</td><td style="border:none;" align="left">cannabisin G</td><td style="border:none;" align="left">antidiabetic activity (glucosidase inhibitor)<sup><xref ref-type="bibr" rid="ref44">44</xref></sup></td></tr></tbody></table></table-wrap><p>Hence,
the entire study as per the experimental analysis and pieces
of evidence-based research on BGR-34 confirms that its constituents
plays many of physiological action in diabetic patients such as decreased
glucose production, increase GLP-1 and&#x00026; GIP, and decrease glucose
absorption, increase insulin secretion, enhanced insulin sensitivity,
increases glucose uptake and storage by muscle, decrease the chances
of diabetic nephropathy, protection from oxidative damage, control
blood glucose level, and block DPP4 enzyme activity. Herewith, TLC-bioautography
coupled with MS revealed numbers of chemical constituents responsible
for the antioxidant and antidiabetic activity in BGR-34. HPTLC profile,
bioautographic assay, and physiological function of BGR-34 are summarized
in a systematic representation and are followed in <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>.</p></sec></sec><sec id="sec3"><label>3</label><title>Conclusions</title><p>BGR-34 showed the presence of a biologically relevant amount of
phenolic and flavonoids. <italic>In vitro</italic> activities showed
the excellent antidiabetic and antioxidant potential of BGR-34. Further,
TLC-bioautographic coupled with MS analysis showed the numbers of
antidiabetic and antioxidant bioactive compounds present in BGR-34.
Hence, it is to conclude that BGR-34 has an immense potential as antidiabetic
and antioxidant mediated via &#x003b1;-amylase, &#x003b1;-glucosidase,
and free-radical inhibition. It controls blood glucose and reduces
FBG, PPG, and HblAc.</p></sec><sec id="sec4"><label>4</label><title>Material and Methods</title><p>HPTLC system (CAMAG, Muttenz, Switzerland), TLC Silica gel 60F<sub>254</sub> (Merck KGaA, 64271 Darmstadt, Germany), and a Water&#x02019;s
ACQUITY UPLC system (Waters Corp., MA, USA)were used for mass spectrometry
analysis. C18 column (ACQUITY UPLC BEH C18 1.7 &#x003bc;m, 2.1 &#x000d7;
100 mm), Mass Lynx V4.1 (Waters, USA), and HPLC water were used. &#x003b1;-Amylase
(CAS RN 9000-90-2), &#x003b1;-glucosidase (CAS number: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://9001-42-7">9001-42-7</uri>), pNPG (CAS number: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://2207-68-3">2207-68-3</uri>), fast blue (CAS number: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://14263-94-6">14263-94-6</uri>), 2,2-diphenyl-1-picrylhydrazyl
(DPPH) (CAS number:1898-66-4), and ascorbic acid (CAS number:50-81-7)
were purchased from Sigma Aldrich Co., St Louis, USA. Folin Ciocalteu
reagent, sodium carbonate, aluminum chloride, sodium acetate, &#x003b1;-amylase,
and glucosidase were procured from Loba Chemie Pvt. Ltd., Mumbai,
India. BGR-34 was procured as a gift sample from AIMIL pharmaceutical
India Ltd. All other solvents and chemicals used were of analytical
grade.</p><sec id="sec4.1"><label>4.1</label><title>Preparation of Sample for Analysis</title><p>The
gift sample of the BGR-34 was obtained from AIMIL Pharmaceutical
Ltd. Thirteen tablet each (three batches) was powdered and processed
for the extraction by the maceration process for 6 h at room temperature
using 100 mL of methanol as a solvent. Then, the contents were filtered,
and the filtrates were dried on a water bath at 50 &#x000b0;C temperature.
After completion of the extraction, the extractive value of each sample
was calculated and the residue were stored in a suitable container
for further analysis at &#x02212;20 &#x000b0;C.<sup><xref ref-type="bibr" rid="ref45">45</xref>,<xref ref-type="bibr" rid="ref46">46</xref></sup></p></sec><sec id="sec4.2"><label>4.2</label><title>Total Phenol and Flavonoid Contents</title><p>The
total phenol content of the different samples was determined
by using the Folin Ciocalteu (FC) method with some modifications.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> Briefly, 5 mg/mL stock solution of extract was
prepared in methanol from each batch of BGR-34. An amount 500 &#x003bc;L
of stock solution from each batch was mixed with 2.5 mL of FC (1:10,
v/v). After mixing, 2.5 mL of sodium bicarbonate solution (7.5%) was
added and allowed to stand for 30 min with intermittent shaking. The
absorbance was measured at 765 nm using a spectrophotometer. The total
phenolic content in BGR-34 was calculated from a calibration curve
of standard gallic acid (10&#x02013;1000 &#x003bc;g/mL), and the result
was expressed as mg gallic acid equivalent/gm of extract (mg GAE/gm
extract).</p><p>The total flavonoid concentration of the samples was
measured by the aluminum chloride method with some modifications.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> Briefly, 5 mg/mL stock solution of extract was
prepared in methanol from each batch of BGR-34. An amount 500 &#x003bc;L
of stock solution from each batch was mixed with 1.5 mL methanol.
After 5 min, 0.1 mL aluminum chloride (10%), 0.1 mL sodium acetate
(1 M), and 2.8 mL water were added. After incubation for 40 min, absorbance
was measured at 415 nm using a spectrophotometer. The total flavonoid
content in BGR-34 was calculated from a calibration curve of standard
rutin (10&#x02013;1000 &#x003bc;g/mL), and the result was expressed as
mg rutin equivalent/gm extract (mg rutin/gm extract).</p></sec><sec id="sec4.3"><label>4.3</label><title>DPPH Free-Radical Scavenging Activity</title><p>The antioxidant
activity of BGR-34 was determined by the described
protocol with some modifications.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> An
amount 20 &#x003bc;L of the sample from each batch was mixed with 180
&#x003bc;L of DPPH solution in methanol (0.01 mM) solution in each defined
well of 96-well plates. The obtained mixtures were incubated for 30
min at room temperature in a relatively dark place, and then absorbance
was read using a spectrophotometer at 517 nm. Ascorbic acid was used
as a positive control and considered the efficacy of BGR-34 in the
proportion of ascorbic acid. The % scavenging curve was plotted against
the extract concentration and their respective IC<sub>50</sub> values.
DPPH scavenging effect was calculated using the following equation<disp-formula id="ueq1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c02995_m001" position="anchor"/></disp-formula></p></sec><sec id="sec4.4"><label>4.4</label><title>&#x003b1;-Amylase
Inhibitory Activity</title><p>The &#x003b1;-amylase inhibitory activity
of BGR-34 was determined
by the described protocol with some modifications.<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> Briefly, 40 &#x003bc;L of the sample from each batch was
mixed with 40 &#x003bc;L of amylase solution (4 units/mL in sodium phosphate
buffer pH 6.7) in each defined well of 96-well plate. The obtained
mixtures were incubated at 37 &#x000b0;C for 30 min. After incubation,
40 &#x003bc;L of starch solution (0.1%) was added to the mixture. After
10 min, 20 &#x003bc;L of hydrochloric acid (I M) was added to stop the
enzyme and substrate reaction and 100 &#x003bc;L of iodide solution
(5 mM iodine +5 mM potassium iodide in distilled water) was added
and the absorbance was measured at 580 nm. Acarbose was used as the
standard.<disp-formula id="ueq2"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c02995_m002" position="anchor"/></disp-formula></p></sec><sec id="sec4.5"><label>4.5</label><title>&#x003b1;-Glucosidase Inhibitory Activity</title><p>The &#x003b1;-glucosidase inhibitory activity of BGR-34 was determined
by the described protocol with some modifications.<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> Briefly, 120 &#x003bc;L of each sample was mixed with 20
&#x003bc;L of &#x003b1;-glucosidase solution (1 U/mL in 0.1 M potassium
phosphate buffer, pH 6.8) in each defined well of 96-well plate. The
obtained mixtures were incubated for 15 min at 37 &#x000b0;C. The reaction
was initiated by adding 20 &#x003bc;L of <italic>para</italic>-nitrophenyl-&#x003b1;-<sc>d</sc>-glucopyranoside (5 mM), and the mixtures were further incubated
for 15 min. The reaction was terminated by adding 80 &#x003bc;L of 0.2
M sodium carbonate, and then absorbance was measured at 405 nm. Acarbose
was used as the standard. The percent inhibition of &#x003b1;-glucosidase
was calculated using the equation<disp-formula id="ueq3"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ao0c02995_m003" position="anchor"/></disp-formula></p></sec><sec id="sec4.6"><label>4.6</label><title>HPTLC
Profiling and Quantitative Estimation
of Berberine and Palmatine</title><p>A 30 mg amounts of each extract
were dissolved individually in HPLC grade methanol and then filtered
using a PTFE membrane filter of 0.2 &#x003bc;M. Further, from the stock
solution, berberine and palmatine were mixed so that the final concentration
of berberine and palmatine was obtained 0.5 mg/mL. Thereafter, with
the help of Camag Linomat-V (CAMAG, Switzerland), 6 &#x003bc;L of the
sample from each of BGR-34 was applied individually with a 6 mm wide-band
length to prewashed and activated Silica gel 60 F254 precoated HPTLC
plates (20 &#x000d7; 10 cm; Merck, Germany) with the nitrogen flow providing
a delivery speed of 150 nL/s. The TLC plate was developed in a presaturated
TLC development chamber containing <italic>n</italic>-butanol:water:glacial
acetic acid (6:3:1, v/v/v) as a solvent system. The plates were prepared
in duplicate and developed to a distance of 7.5 cm at room temperature
(25 &#x000b0;C). After drying the spots on the developed plates, one
was visualized under visible (white), short UV (254 nm), and long
UV (366 nm) light. The other plate was sprayed with anisaldehyde-sulfuric
acid reagent and heated for 5 min for color reaction and visualized
at 540 nm. The quantification of berberine and palmatine was carried
out at 366 nm using a Camag TLC scanner III using Wincats1.2.3 software.<sup><xref ref-type="bibr" rid="ref26">26</xref></sup></p></sec><sec id="sec4.7"><label>4.7</label><title>TLC-Bioautography for Antioxidants
Activity/DPPH
Free-Radical Scavenging Activity</title><p>TLC-bioautographic-based
determinations of DPPH free-radical scavenging active compounds were
identified as per the protocol with some modifications.<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> A stock solution of DPPH (5 mM) was prepared
in methanol, and the stock solution was kept at 4 &#x000b0;C. Further,
the methanolic extract of BGR-34 6 &#x003bc;L was applied in duplicate
to a TLC plate G<sub>60</sub> F<sub>254</sub> at a distance of 15
mm using Camag Linomat automatic sample applicator. The plate was
developed in a TLC development chamber containing <italic>n</italic>-butanol:water:glacial acetic acid (6:3:1, v/v/v) as a solvent system.
Thereafter, the developed TLC plate was dried and cut from mid to
separate both the tracks. Further, half of plate was sprayed/dipped
in methanolic solution of DPPH. The yellowish color bands appeared
against the purple background, indicating that the bands are active
as an antioxidant.</p></sec><sec id="sec4.8"><label>4.8</label><title>TLC-Bioautography for &#x003b1;-Amylase Activity</title><p>TLC-bioautographic-based
determination of &#x003b1;-amylase active
compounds was identified as per the protocol with some modifications.<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> Briefly, a stock solution of &#x003b1;-amylase
(10 mg) was prepared in 20 mL of sodium acetate buffer solution and
the stock solution was kept at 4 &#x000b0;C. Thereafter, after the sample
was applied, it was developed and separated on two halves as above.
The developed plate half portion was then dipped in a prepared enzyme
solution and incubated for 1.5 h in a humid desiccator containing
a little amount of enough water inside the chamber so that the plate
should not come in contact with water but enough to maintain the humid
environment inside the chamber. After the incubation period, the plate
was dipped in 1% of the starch solution as substrate and further incubated
for 20&#x02013;30 min for enzyme and substrate reaction. Finally, the
plate was dipped in Gram&#x02019;s iodine solution and the &#x003b1;-amylase
activity was visible on the TLC plate by the appearance of the violet
spot on a dark brown color background and then images were captured
of developed bioautogram.</p></sec><sec id="sec4.9"><label>4.9</label><title>TLC-Bioautography for &#x003b1;-Glucosidase
Activity</title><p>Bioautographic-based determination of &#x003b1;-glucosidase
active compounds was identified as per the protocol with some modification.<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> Briefly, a stock solution of &#x003b1;-glucosidase
(100 U) was prepared in 10 mL of sodium acetate buffer solution and
the stock solution was kept at 4 &#x000b0;C. Thereafter, the sample was
applied and developed in solvent system; after drying it was separated
in two halves from mid as above. The developed plate was then dipped
in a prepared enzyme solution and incubated for 1&#x02013;2 h in a
humid desiccator containing a little amount of enough water inside
the chamber so that the plate should not come in contact with water
but enough to maintain the humid environment inside the chamber. After
the incubation period, the TLC plate was further dipped in the mixture
of 2-naphthyl-&#x003b1;-<sc>d</sc>-glucopyranoside (2 mg/mL) and Fast-Blue
B salt solution (2.5 mg/mL) in a ratio of 1: 1 as the substrate for
enzyme and substrate reaction and incubated for 2 h for completion
of the reaction. Glucosidase activity was visible on the TLC plate
by the appearance of the white spot on a purple/violet background,
and the images were captured of developed bioautogram.</p></sec><sec id="sec4.10"><label>4.10</label><title>TLC-Bioautography-Based Determination of
Antioxidants, &#x003b1;-Amylase, and &#x003b1;-Glucosidase Compounds</title><p>To identify antioxidant and &#x003b1;-amylase and &#x003b1;-glucosidase
active compounds present in the methanolic extract of BGR-34. The
developed different TLC-bioautograms with active zones of DPPH, amylase,
and glucosidase inhibition were kept simultaneously in parallel with
the controlled TLC plate (second half, track), and the targeted spots
were scrapped which were lying in parallel of the active zone. The
scrapped spot materials with silica gel were dissolved in HPLC grade
methanol through vortex and centrifuge at 4000 RPM for 10 min to separate
silica gel particles. The supernatants were separated and filtered
(0.2 &#x003bc;M PTFE membrane filter). The obtained samples were processed
for mass spectrometry (MS) analysis.<sup><xref ref-type="bibr" rid="ref48">48</xref></sup></p></sec><sec id="sec4.11"><label>4.11</label><title>MS Analysis of Bioactive Metabolites Isolated
from TLC</title><p>The obtained sample from the bioautographic assay,
MS analysis, was coupled to identify the active metabolite based on
their molecular mass as obtained from spectral data. The MS was performed
on a Water&#x02019;s ACQUITY UPLC (TM) system (Waters Corp., MA, USA)
equipped with a binary solvent delivery system, an auto-sampler, column
manager, and a tunable MS detector operated through Empower software
(Waters, Manchester, UK). For optimum chromatographic separation,
acetonitrile (A) and water (B) were run on a monolithic capillary
silica-based C18 column (ACQUITY UPLC(R) BEH C18 1.7 &#x003bc;m, 2.1
&#x000d7; 100 mm). The flow rate of the nebulizer gas was set at 500
L/h; for cone gas, it was set at 50 L/h, and the source temperature
was fixed at 100 &#x000b0;C. The capillary and cone voltage was set at
3.0 and 40 KV, respectively. For collision, argon was employed at
a pressure of 5.3 &#x000d7; 10<sup>&#x02013;5</sup> torr. The obtained
spectral data from MS was processed by Mass Lynx V4.1 (Waters, USA)
and further used for metabolomics analysis of the samples. Separated
metabolites present in different samples were tentatively identified
based on their <italic>m/z</italic> values from mass data sources
such as Mass Bank, PubChem, Drug Bank, ChemSpider, and literature.<sup><xref ref-type="bibr" rid="ref47">47</xref>,<xref ref-type="bibr" rid="ref49">49</xref></sup></p></sec></sec></body><back><notes notes-type="COI-statement" id="NOTES-d7e1974-autogenerated"><p>The authors declare no
competing financial interest.</p></notes><ack><title>Acknowledgments</title><p>We are thankful to
AIMIL Pharmaceuticals (India)
Ltd., for providing the BGR sample as a gift.</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Khan</surname><given-names>W.</given-names></name>; <name><surname>Zahiruddin</surname><given-names>S.</given-names></name>; <name><surname>Ahmad</surname><given-names>S.</given-names></name>
<article-title>Diabetes-Associated Complication
and Some Indian Traditional Plants Used for Its Management</article-title>. <source>Stud. Nat. Prod. Chem.</source>
<year>2020</year>, <volume>66</volume>, <fpage>117</fpage>&#x02013;<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-12-817907-9.00005-2</pub-id>.</mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Mohan</surname><given-names>V.</given-names></name>; <name><surname>Sandeep</surname><given-names>S.</given-names></name>; <name><surname>Deepa</surname><given-names>R.</given-names></name>; <name><surname>Shah</surname><given-names>B.</given-names></name>; <name><surname>Varghese</surname><given-names>C.</given-names></name>
<article-title>Epidemiology
of Type 2 Diabetes: Indian Scenario</article-title>. <source>Indian
J. Med. Res.</source>
<year>2007</year>, <volume>125</volume>, <fpage>217</fpage>&#x02013;<lpage>230</lpage>.<pub-id pub-id-type="pmid">17496352</pub-id></mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Van
Quan</surname><given-names>N.</given-names></name>; <name><surname>Xuan</surname><given-names>T. D.</given-names></name>; <name><surname>Tran</surname><given-names>H.-D.</given-names></name>; <name><surname>Thuy</surname><given-names>N. T. D.</given-names></name>; <name><surname>Trang</surname><given-names>L. T.</given-names></name>; <name><surname>Huong</surname><given-names>C. T.</given-names></name>; <name><surname>Andriana</surname><given-names>Y.</given-names></name>; <name><surname>Tuyen</surname><given-names>P. T.</given-names></name>
<article-title>Antioxidant, &#x003b1;-Amylase
and &#x003b1;-Glucosidase Inhibitory Activities and Potential Constituents
of <italic>Canarium Tramdenum</italic> Bark</article-title>. <source>Molecules</source>
<year>2019</year>, <volume>24</volume>, <fpage>605</fpage><pub-id pub-id-type="doi">10.3390/molecules24030605</pub-id>.</mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="undeclared" id="cit4"><person-group person-group-type="allauthors"><collab>WHO</collab></person-group><source>World Health Day 2016: WHO Calls for Global Action to Halt
Rise in and Improve Care for People with Diabetes</source>; <publisher-name>WHO</publisher-name>: <year>2016</year>.</mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="book" id="cit5"><person-group person-group-type="allauthors"><name><surname>Cho</surname><given-names>N. H.</given-names></name>; <name><surname>Whiting</surname><given-names>D.</given-names></name>; <name><surname>Guariguata</surname><given-names>L.</given-names></name>; <name><surname>Montoya</surname><given-names>P. A.</given-names></name>; <name><surname>Forouhi</surname><given-names>N.</given-names></name>; <name><surname>Hambleton</surname><given-names>I.</given-names></name>; <name><surname>Li</surname><given-names>R.</given-names></name>; <name><surname>Majeed</surname><given-names>A.</given-names></name>; <name><surname>Mbanya</surname><given-names>J. C.</given-names></name>; <name><surname>Motala</surname><given-names>A.</given-names></name>; <name><surname>Narayan</surname><given-names>K. M.</given-names></name></person-group><source>IDF Diabetes Atlas</source>; <edition>9</edition><italic>th Edn.</italic>; <publisher-name>International
Diabetes Federation</publisher-name>: <publisher-loc>Brussels, Belgium</publisher-loc>, 2019<italic>,</italic><year>2013</year>.</mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Salehi</surname><given-names>B.</given-names></name>; <name><surname>Ata</surname><given-names>A.</given-names></name>; <name><surname>Kumar</surname><given-names>N. V. A.</given-names></name>; <name><surname>Sharopov</surname><given-names>F.</given-names></name>; <name><surname>Ram&#x000ed;rez-Alarc&#x000f3;n</surname><given-names>K.</given-names></name>; <name><surname>Ruiz-Ortega</surname><given-names>A.</given-names></name>; <name><surname>Ayatollahi</surname><given-names>S. A.</given-names></name>; <name><surname>Fokou</surname><given-names>P. V. T.</given-names></name>; <name><surname>Kobarfard</surname><given-names>F.</given-names></name>; <name><surname>Zakaria</surname><given-names>Z. A.</given-names></name>; <name><surname>Iriti</surname><given-names>M.</given-names></name>; <name><surname>Taheri</surname><given-names>Y.</given-names></name>; <name><surname>Martorell</surname><given-names>M.</given-names></name>; <name><surname>Sureda</surname><given-names>A.</given-names></name>; <name><surname>Setzer</surname><given-names>W. N.</given-names></name>; <name><surname>Durazzo</surname><given-names>A.</given-names></name>; <name><surname>Lucarini</surname><given-names>M.</given-names></name>; <name><surname>Santini</surname><given-names>A.</given-names></name>; <name><surname>Capasso</surname><given-names>R.</given-names></name>; <name><surname>Ostrander</surname><given-names>E. A.</given-names></name>; <name><surname>Rahman</surname><given-names>A.-u.</given-names></name>; <name><surname>Choudhary</surname><given-names>M. I.</given-names></name>; <name><surname>Cho</surname><given-names>W. C.</given-names></name>; <name><surname>Sharifi-Rad</surname><given-names>J.</given-names></name>
<article-title>Antidiabetic
Potential of Medicinal Plants and Their Active Components</article-title>. <source>Biomolecules</source>
<year>2019</year>, <volume>9</volume>, <fpage>551</fpage><pub-id pub-id-type="doi">10.3390/biom9100551</pub-id>.</mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Fitzgerald</surname><given-names>M.</given-names></name>; <name><surname>Heinrich</surname><given-names>M.</given-names></name>; <name><surname>Booker</surname><given-names>A.</given-names></name>
<article-title>Medicinal
Plant Analysis: A Historical
and Regional Discussion of Emergent Complex Techniques</article-title>. <source>Front. Pharmacol.</source>
<year>2019</year>, <volume>10</volume>, <fpage>1480</fpage><pub-id pub-id-type="doi">10.3389/fphar.2019.01480</pub-id>.<pub-id pub-id-type="pmid">31998121</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Br&#x000e4;m</surname><given-names>S.</given-names></name>; <name><surname>Wolfram</surname><given-names>E.</given-names></name>
<article-title>Recent Advances in
Effect-Directed Enzyme Assays Based
on Thin-Layer Chromatography</article-title>. <source>Phytochem. Anal.</source>
<year>2017</year>, <volume>28</volume>, <fpage>74</fpage>&#x02013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1002/pca.2669</pub-id>.<pub-id pub-id-type="pmid">28146298</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Gupta</surname><given-names>B. P.</given-names></name>; <name><surname>Sharma</surname><given-names>I.</given-names></name>; <name><surname>Kohli</surname><given-names>N.</given-names></name>; <name><surname>Sharma</surname><given-names>S.</given-names></name>; <name><surname>Rathi</surname><given-names>A.</given-names></name>; <name><surname>Sharma</surname><given-names>A. K.</given-names></name>
<article-title>Preliminary Clinical Assessment and Non- Toxicity Evaluation
of an Ayurvedic Formulation BGR-34 in NIDDM</article-title>. <source>J. Tradit. Complementary Med.</source>
<year>2018</year>, <volume>8</volume>, <fpage>506</fpage>&#x02013;<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1016/j.jtcme.2017.11.004</pub-id>.</mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Parveen</surname><given-names>S.</given-names></name>; <name><surname>Ansari</surname><given-names>M. H. R.</given-names></name>; <name><surname>Parveen</surname><given-names>R.</given-names></name>; <name><surname>Khan</surname><given-names>W.</given-names></name>; <name><surname>Ahmad</surname><given-names>S.</given-names></name>; <name><surname>Husain</surname><given-names>S. A.</given-names></name>
<article-title>Chromatography Based
Metabolomics and in Silico Screening
of Gymnema Sylvestre Leaf Extract for Its Antidiabetic Potential</article-title>. <source>J. Evidence-based Complementary Altern. Med.</source>
<year>2019</year>, <volume>2019</volume>, <fpage>1</fpage><pub-id pub-id-type="doi">10.1155/2019/7523159</pub-id>.</mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Premanath</surname><given-names>R.</given-names></name>; <name><surname>Lakshmi</surname><given-names>N.</given-names></name>
<article-title>Studies on Anti-Oxidant Activity of Tinospora Cordifolia
(Miers.) Leaves Using in Vitro Models</article-title>. <source>J. Am.
Sci.</source>
<year>2010</year>, <volume>6</volume>, <fpage>736</fpage>&#x02013;<lpage>743</lpage>.</mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Al-Dabbagh</surname><given-names>B.</given-names></name>; <name><surname>Elhaty</surname><given-names>I. A.</given-names></name>; <name><surname>Al Hrout</surname><given-names>A.</given-names></name>; <name><surname>Al Sakkaf</surname><given-names>R.</given-names></name>; <name><surname>El-Awady</surname><given-names>R.</given-names></name>; <name><surname>Ashraf</surname><given-names>S. S.</given-names></name>; <name><surname>Amin</surname><given-names>A.</given-names></name>
<article-title>Antioxidant and Anticancer
Activities of Trigonella Foenum-Graecum, Cassia Acutifolia and Rhazya
Stricta</article-title>. <source>BMC Complementary Altern. Med.</source>
<year>2018</year>, <volume>18</volume>, <fpage>240</fpage><pub-id pub-id-type="doi">10.1186/s12906-018-2285-7</pub-id>.</mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Bhatt</surname><given-names>L. R.</given-names></name>; <name><surname>Wagle</surname><given-names>B.</given-names></name>; <name><surname>Adhikari</surname><given-names>M.</given-names></name>; <name><surname>Bhusal</surname><given-names>S.</given-names></name>; <name><surname>Giri</surname><given-names>A.</given-names></name>; <name><surname>Bhattarai</surname><given-names>S.</given-names></name>
<article-title>Antioxidant Activity, Total Phenolic
and Flavonoid
Content of Berberis Aristata DC. and Berberis Thomsoniana C.K. Schneid.
from Sagarmatha National Park, Nepal</article-title>. <source>Pharmacogn.
J.</source>
<year>2018</year>, <volume>10</volume>, <fpage>167</fpage>&#x02013;<lpage>171</lpage>.</mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Gupta</surname><given-names>P.</given-names></name>; <name><surname>Jain</surname><given-names>V.</given-names></name>; <name><surname>Pareek</surname><given-names>A.</given-names></name>; <name><surname>Kumari</surname><given-names>P.</given-names></name>; <name><surname>Singh</surname><given-names>R.</given-names></name>; <name><surname>Agarwal</surname><given-names>P.</given-names></name>; <name><surname>Sharma</surname><given-names>V.</given-names></name>
<article-title>Evaluation
of Effect of Alcoholic
Extract of Heartwood of Pterocarpus Marsupium on in Vitro Antioxidant,
Anti-Glycation, Sorbitol Accumulation and Inhibition of Aldose Reductase
Activity</article-title>. <source>J. Tradit. Complementary Med.</source>
<year>2017</year>, <volume>7</volume>, <fpage>307</fpage>&#x02013;<lpage>314</lpage>. <pub-id pub-id-type="doi">10.1016/j.jtcme.2016.11.001</pub-id>.</mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Aryaeian</surname><given-names>N.</given-names></name>; <name><surname>Sedehi</surname><given-names>S. K.</given-names></name>; <name><surname>Arablou</surname><given-names>T.</given-names></name>
<article-title>Polyphenols
and Their Effects on
Diabetes Management: A Review</article-title>. <source>Med. J. Islam.
Repub. Iran</source>
<year>2017</year>, <volume>31</volume>, <fpage>134</fpage><pub-id pub-id-type="doi">10.14196/mjiri.31.134</pub-id>.<pub-id pub-id-type="pmid">29951434</pub-id></mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Sekhon-Loodu</surname><given-names>S.</given-names></name>; <name><surname>Rupasinghe</surname><given-names>H. P. V.</given-names></name>
<article-title>Evaluation of Antioxidant, Antidiabetic
and Antiobesity
Potential of Selected Traditional Medicinal Plants</article-title>. <source>Front. Nutr.</source>
<year>2019</year>, <volume>6</volume>, <fpage>53</fpage><pub-id pub-id-type="doi">10.3389/fnut.2019.00053</pub-id>.<pub-id pub-id-type="pmid">31106207</pub-id></mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Tan</surname><given-names>B. L.</given-names></name>; <name><surname>Norhaizan</surname><given-names>M. E.</given-names></name>; <name><surname>Liew</surname><given-names>W.-P.-P.</given-names></name>; <name><surname>Rahman</surname><given-names>H. S.</given-names></name>
<article-title>Antioxidant and
Oxidative Stress: A Mutual Interplay in Age-Related Diseases</article-title>. <source>Front. Pharmacol.</source>
<year>2018</year>, <volume>9</volume>, <fpage>1162</fpage><pub-id pub-id-type="doi">10.3389/fphar.2018.01162</pub-id>.<pub-id pub-id-type="pmid">30405405</pub-id></mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Sarian</surname><given-names>M. N.</given-names></name>; <name><surname>Ahmed</surname><given-names>Q. U.</given-names></name>; <name><surname>So&#x02019;Ad</surname><given-names>S. Z. M.</given-names></name>; <name><surname>Alhassan</surname><given-names>A. M.</given-names></name>; <name><surname>Murugesu</surname><given-names>S.</given-names></name>; <name><surname>Perumal</surname><given-names>V.</given-names></name>; <name><surname>Mohamad</surname><given-names>S. N. A. S.</given-names></name>; <name><surname>Khatib</surname><given-names>A.</given-names></name>; <name><surname>Latip</surname><given-names>J.</given-names></name>
<article-title>Antioxidant
and Antidiabetic Effects of Flavonoids: A Structure-Activity Relationship
Based Study</article-title>. <source>Biomed Res. Int.</source>
<year>2017</year>, <volume>2017</volume>, <fpage>1</fpage><pub-id pub-id-type="doi">10.1155/2017/8386065</pub-id>.</mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Sahu</surname><given-names>G. K.</given-names></name>; <name><surname>Upadhyay</surname><given-names>S.</given-names></name>; <name><surname>Panna</surname><given-names>S. M.</given-names></name>
<article-title>Salivary Alpha Amylase Activity in
Human Beings of Different Age Groups Subjected to Psychological Stress</article-title>. <source>Indian J. Clin. Biochem.</source>
<year>2014</year>, <volume>29</volume>, <fpage>485</fpage>&#x02013;<lpage>490</lpage>. <pub-id pub-id-type="doi">10.1007/s12291-013-0388-y</pub-id>.<pub-id pub-id-type="pmid">25298630</pub-id></mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Bae</surname><given-names>J. H.</given-names></name>; <name><surname>Kim</surname><given-names>L. K.</given-names></name>; <name><surname>Min</surname><given-names>S. H.</given-names></name>; <name><surname>Ahn</surname><given-names>C. H.</given-names></name>; <name><surname>Cho</surname><given-names>Y. M.</given-names></name>
<article-title>Postprandial
Glucose-Lowering Effect of Premeal Consumption of Protein-Enriched,
Dietary Fiber-Fortified Bar in Individuals with Type 2 Diabetes Mellitus
or Normal Glucose Tolerance</article-title>. <source>J. Diabetes Invest.</source>
<year>2018</year>, <volume>9</volume>, <fpage>1110</fpage>&#x02013;<lpage>1118</lpage>. <pub-id pub-id-type="doi">10.1111/jdi.12831</pub-id>.</mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Dineshkumar</surname><given-names>B.</given-names></name>; <name><surname>Mitra</surname><given-names>A.</given-names></name>; <name><surname>Manjunatha</surname><given-names>M.</given-names></name>
<article-title>A Comparative Study of Alpha Amylase
Inhibitory Activities of Common Anti-Diabetic Plants at Kharagpur
1 Block</article-title>. <source>Int. J. Green Pharm.</source>
<year>2010</year>, <volume>4</volume>, <fpage>115</fpage>&#x02013;<lpage>121</lpage>. <pub-id pub-id-type="doi">10.22377/ijgp.v4i2.131</pub-id>.</mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Matough</surname><given-names>F. A.</given-names></name>; <name><surname>Budin</surname><given-names>S. B.</given-names></name>; <name><surname>Hamid</surname><given-names>Z. A.</given-names></name>; <name><surname>Alwahaibi</surname><given-names>N.</given-names></name>; <name><surname>Mohamed</surname><given-names>J.</given-names></name>
<article-title>The Role of Oxidative Stress and Antioxidants in Diabetic
Complications</article-title>. <source>Sultan Qaboos Univ. Med. J.</source>
<year>2012</year>, <volume>12</volume>, <fpage>5</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.12816/0003082</pub-id>.<pub-id pub-id-type="pmid">22375253</pub-id></mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Sugihara</surname><given-names>H.</given-names></name>; <name><surname>Nagao</surname><given-names>M.</given-names></name>; <name><surname>Harada</surname><given-names>T.</given-names></name>; <name><surname>Nakajima</surname><given-names>Y.</given-names></name>; <name><surname>Tanimura-Inagaki</surname><given-names>K.</given-names></name>; <name><surname>Okajima</surname><given-names>F.</given-names></name>; <name><surname>Tamura</surname><given-names>H.</given-names></name>; <name><surname>Inazawa</surname><given-names>T.</given-names></name>; <name><surname>Otonari</surname><given-names>T.</given-names></name>; <name><surname>Kawakami</surname><given-names>M.</given-names></name>; <name><surname>Oikawa</surname><given-names>S.</given-names></name>
<article-title>Comparison of Three &#x003b1;-Glucosidase
Inhibitors for Glycemic Control and Bodyweight Reduction in Japanese
Patients with Obese Type 2 Diabetes</article-title>. <source>J. Diabetes
Invest.</source>
<year>2014</year>, <volume>5</volume>, <fpage>206</fpage>&#x02013;<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1111/jdi.12135</pub-id>.</mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Wachters-Hagedoorn</surname><given-names>R.
E.</given-names></name>; <name><surname>Priebe</surname><given-names>M. G.</given-names></name>; <name><surname>Heimweg</surname><given-names>J. A. J.</given-names></name>; <name><surname>Heiner</surname><given-names>A. M.</given-names></name>; <name><surname>Elzinga</surname><given-names>H.</given-names></name>; <name><surname>Stellaard</surname><given-names>F.</given-names></name>; <name><surname>Vonk</surname><given-names>R. J.</given-names></name>
<article-title>Low-Dose Acarbose Does Not Delay
Digestion of Starch but Reduces Its Bioavailability</article-title>. <source>Diabetic Med.</source>
<year>2007</year>, <volume>24</volume>, <fpage>600</fpage>&#x02013;<lpage>606</lpage>. <pub-id pub-id-type="doi">10.1111/j.1464-5491.2007.02115.x</pub-id>.<pub-id pub-id-type="pmid">17381499</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name><surname>Van
de Laar</surname><given-names>F. A.</given-names></name>
<article-title>Alpha-Glucosidase Inhibitors in the Early Treatment
of Type 2 Diabetes</article-title>. <source>Vasc. Health Risk Manage.</source>
<year>2008</year>, <volume>4</volume>, <fpage>1189</fpage>&#x02013;<lpage>1195</lpage>. <pub-id pub-id-type="doi">10.2147/VHRM.S3119</pub-id>.</mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Anjum</surname><given-names>V.</given-names></name>; <name><surname>Arora</surname><given-names>P.</given-names></name>; <name><surname>Ansari</surname><given-names>S. H.</given-names></name>; <name><surname>Najmi</surname><given-names>A. K.</given-names></name>; <name><surname>Ahmad</surname><given-names>S.</given-names></name>
<article-title>Antithrombocytopenic
and Immunomodulatory Potential of Metabolically Characterized Aqueous
Extract of Carica Papaya Leaves</article-title>. <source>Pharm. Biol.</source>
<year>2017</year>, <volume>55</volume>, <fpage>2043</fpage>&#x02013;<lpage>2056</lpage>. <pub-id pub-id-type="doi">10.1080/13880209.2017.1346690</pub-id>.<pub-id pub-id-type="pmid">28836477</pub-id></mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Kahkeshani</surname><given-names>N.</given-names></name>; <name><surname>Farzaei</surname><given-names>F.</given-names></name>; <name><surname>Fotouhi</surname><given-names>M.</given-names></name>; <name><surname>Alavi</surname><given-names>S. S.</given-names></name>; <name><surname>Bahramsoltani</surname><given-names>R.</given-names></name>; <name><surname>Naseri</surname><given-names>R.</given-names></name>; <name><surname>Momtaz</surname><given-names>S.</given-names></name>; <name><surname>Abbasabadi</surname><given-names>Z.</given-names></name>; <name><surname>Rahimi</surname><given-names>R.</given-names></name>; <name><surname>Farzaei</surname><given-names>M. H.</given-names></name>; <name><surname>Bishayee</surname><given-names>A.</given-names></name>
<article-title>Pharmacological
Effects
of Gallic Acid in Health and Disease: A Mechanistic Review</article-title>. <source>Iran. J. Basic Med. Sci.</source>
<year>2019</year>, <volume>22</volume>, <fpage>225</fpage>&#x02013;<lpage>237</lpage>. <pub-id pub-id-type="doi">10.22038/ijbms.2019.32806.7897</pub-id>.<pub-id pub-id-type="pmid">31156781</pub-id></mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>Xu</surname><given-names>D.</given-names></name>; <name><surname>Hu</surname><given-names>M.-J.</given-names></name>; <name><surname>Wang</surname><given-names>Y.-Q.</given-names></name>; <name><surname>Cui</surname><given-names>Y.-L.</given-names></name>
<article-title>Antioxidant Activities
of Quercetin and Its Complexes for Medicinal Application</article-title>. <source>Molecules</source>
<year>2019</year>, <volume>24</volume>, <fpage>1123</fpage><pub-id pub-id-type="doi">10.3390/molecules24061123</pub-id>.</mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name><surname>&#x00160;ilarov&#x000e1;</surname><given-names>P.</given-names></name>; <name><surname>Boulekbache-Makhlouf</surname><given-names>L.</given-names></name>; <name><surname>Pellati</surname><given-names>F.</given-names></name>; <name><surname>&#x0010c;eslov&#x000e1;</surname><given-names>L.</given-names></name>
<article-title>Monitoring
of Chlorogenic Acid and Antioxidant Capacity of Solanum Melongena
L. (Eggplant) under Different Heat and Storage Treatments</article-title>. <source>Antioxidants</source>
<year>2019</year>, <volume>8</volume>, <fpage>234</fpage><pub-id pub-id-type="doi">10.3390/antiox8070234</pub-id>.</mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>Gori</surname><given-names>A.</given-names></name>; <name><surname>Ferrini</surname><given-names>F.</given-names></name>; <name><surname>Marzano</surname><given-names>M. C.</given-names></name>; <name><surname>Tattini</surname><given-names>M.</given-names></name>; <name><surname>Centritto</surname><given-names>M.</given-names></name>; <name><surname>Baratto</surname><given-names>M. C.</given-names></name>; <name><surname>Pogni</surname><given-names>R.</given-names></name>; <name><surname>Brunetti</surname><given-names>C.</given-names></name>
<article-title>Characterisation and
Antioxidant Activity of Crude Extract and Polyphenolic Rich Fractions
from <italic>C. incanus Leaves</italic></article-title>. <source>Int.
J. Mol. Sci.</source>
<year>2016</year>, <volume>17</volume>, <fpage>1344</fpage><pub-id pub-id-type="doi">10.3390/ijms17081344</pub-id>.</mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Viapiana</surname><given-names>A.</given-names></name>; <name><surname>Wesolowski</surname><given-names>M.</given-names></name>
<article-title>The Phenolic Contents and Antioxidant
Activities of
Infusions of <italic>Sambucus Nigra L</italic></article-title>. <source>Plant Foods Hum. Nutr.</source>
<year>2017</year>, <volume>72</volume>, <fpage>82</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1007/s11130-016-0594-x</pub-id>.<pub-id pub-id-type="pmid">28084608</pub-id></mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>Ran</surname><given-names>Q.</given-names></name>; <name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Wang</surname><given-names>L.</given-names></name>; <name><surname>Zeng</surname><given-names>H.</given-names></name>; <name><surname>Yang</surname><given-names>X.-b.</given-names></name>; <name><surname>Huang</surname><given-names>Q.-w.</given-names></name>
<article-title>Rhizoma Coptidis
as a Potential Treatment Agent for
Type 2 Diabetes Mellitus and the Underlying Mechanisms: A Review</article-title>. <source>Front. Pharmacol.</source>
<year>2019</year>, <volume>10</volume>, <fpage>805</fpage><pub-id pub-id-type="doi">10.3389/fphar.2019.00805</pub-id>.<pub-id pub-id-type="pmid">31396083</pub-id></mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>Cicero</surname><given-names>A. F. G.</given-names></name>; <name><surname>Tartagni</surname><given-names>E.</given-names></name>
<article-title>Antidiabetic Properties
of Berberine: From Cellular
Pharmacology to Clinical Effects</article-title>. <source>Hosp. Pract.</source>
<year>2015</year>, <volume>40</volume>, <fpage>56</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.3810/hp.2012.04.970</pub-id>.</mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>Jhong</surname><given-names>C.-H.</given-names></name>; <name><surname>Riyaphan</surname><given-names>J.</given-names></name>; <name><surname>Lin</surname><given-names>S.-H.</given-names></name>; <name><surname>Chia</surname><given-names>Y.-C.</given-names></name>; <name><surname>Weng</surname><given-names>C.-F.</given-names></name>
<article-title>Screening
Alpha-Glucosidase and Alpha-Amylase Inhibitors from Natural Compounds
by Molecular Docking in Silico</article-title>. <source>BioFactors</source>
<year>2015</year>, <volume>41</volume>, <fpage>242</fpage>&#x02013;<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1002/biof.1219</pub-id>.<pub-id pub-id-type="pmid">26154585</pub-id></mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Tintu</surname><given-names>I.</given-names></name>; <name><surname>Dileep</surname><given-names>K. V.</given-names></name>; <name><surname>Augustine</surname><given-names>A.</given-names></name>; <name><surname>Sadasivan</surname><given-names>C.</given-names></name>
<article-title>An Isoquinoline
Alkaloid, Berberine, Can Inhibit Fungal Alpha Amylase: Enzyme Kinetic
and Molecular Modeling Studies</article-title>. <source>Chem. Biol.
Drug Des.</source>
<year>2012</year>, <volume>80</volume>, <fpage>554</fpage>&#x02013;<lpage>560</lpage>. <pub-id pub-id-type="doi">10.1111/j.1747-0285.2012.01426.x</pub-id>.<pub-id pub-id-type="pmid">22690956</pub-id></mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name><surname>Ponnulakshmi</surname><given-names>R.</given-names></name>; <name><surname>Shyamaladevi</surname><given-names>B.</given-names></name>; <name><surname>Vijayalakshmi</surname><given-names>P.</given-names></name>; <name><surname>Selvaraj</surname><given-names>J.</given-names></name>
<article-title>In Silico and in Vivo
Analysis to Identify the Antidiabetic Activity of Beta Sitosterol
in Adipose Tissue of High Fat Diet and Sucrose Induced Type-2 Diabetic
Experimental Rats</article-title>. <source>Toxicol. Mech. Methods</source>
<year>2019</year>, <volume>29</volume>, <fpage>276</fpage>&#x02013;<lpage>290</lpage>. <pub-id pub-id-type="doi">10.1080/15376516.2018.1545815</pub-id>.<pub-id pub-id-type="pmid">30461321</pub-id></mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Lankatillake</surname><given-names>C.</given-names></name>; <name><surname>Huynh</surname><given-names>T.</given-names></name>; <name><surname>Dias</surname><given-names>D. A.</given-names></name>
<article-title>Understanding
Glycaemic Control and
Current Approaches for Screening Antidiabetic Natural Products from
Evidence-Based Medicinal Plants</article-title>. <source>Plant Methods</source>
<year>2019</year>, <volume>15</volume>, <fpage>105</fpage><pub-id pub-id-type="doi">10.1186/s13007-019-0487-8</pub-id>.<pub-id pub-id-type="pmid">31516543</pub-id></mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name><surname>Gharib</surname><given-names>E.</given-names></name>; <name><surname>Kouhsari</surname><given-names>S. M.</given-names></name>
<article-title>Study of the Antidiabetic Activity
of Punica Granatum
L. Fruits Aqueous Extract on the Alloxan-Diabetic Wistar Rats</article-title>. <source>Iran. J. Pharm. Res.</source>
<year>2019</year>, <volume>18</volume>, <fpage>358</fpage>&#x02013;<lpage>368</lpage>.<pub-id pub-id-type="pmid">31089370</pub-id></mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name><surname>Ning</surname><given-names>Z.-w.</given-names></name>; <name><surname>Zhai</surname><given-names>L.-x.</given-names></name>; <name><surname>Huang</surname><given-names>T.</given-names></name>; <name><surname>Peng</surname><given-names>J.</given-names></name>; <name><surname>Hu</surname><given-names>D.</given-names></name>; <name><surname>Xiao</surname><given-names>H.-t.</given-names></name>; <name><surname>Wen</surname><given-names>B.</given-names></name>; <name><surname>Lin</surname><given-names>C.-y.</given-names></name>; <name><surname>Zhao</surname><given-names>L.</given-names></name>; <name><surname>Bian</surname><given-names>Z.-x.</given-names></name>
<article-title>Identification of &#x003b1;-Glucosidase Inhibitors from:
Cyclocarya Paliurus Tea Leaves Using UF-UPLC-Q/TOF-MS/MS and Molecular
Docking</article-title>. <source>Food Funct.</source>
<year>2019</year>, <volume>10</volume>, <fpage>1893</fpage>&#x02013;<lpage>1902</lpage>. <pub-id pub-id-type="doi">10.1039/C8FO01845F</pub-id>.<pub-id pub-id-type="pmid">30865735</pub-id></mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name><surname>Bharti</surname><given-names>S. K.</given-names></name>; <name><surname>Krishnan</surname><given-names>S.</given-names></name>; <name><surname>Kumar</surname><given-names>A.</given-names></name>; <name><surname>Kumar</surname><given-names>A.</given-names></name>
<article-title>Antidiabetic Phytoconstituents
and Their Mode of Action on Metabolic Pathways</article-title>. <source>Ther. Adv. Endocrinol. Metab.</source>
<year>2018</year>, <volume>9</volume>, <fpage>81</fpage>&#x02013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1177/2042018818755019</pub-id>.<pub-id pub-id-type="pmid">29492244</pub-id></mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name><surname>Rahman</surname><given-names>N.</given-names></name>; <name><surname>Muhammad</surname><given-names>I.</given-names></name>; <name><surname>Nayab</surname><given-names>G.-E.</given-names></name>; <name><surname>Khan</surname><given-names>H.</given-names></name>; <name><surname>Aschner</surname><given-names>M.</given-names></name>; <name><surname>Filosa</surname><given-names>R.</given-names></name>; <name><surname>Daglia</surname><given-names>M.</given-names></name>
<article-title>Molecular
Docking of Isolated Alkaloids
for Possible &#x003b1;-Glucosidase Inhibition</article-title>. <source>Biomolecules</source>
<year>2019</year>, <volume>9</volume>, <fpage>544</fpage><pub-id pub-id-type="doi">10.3390/biom9100544</pub-id>.</mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name><surname>Ajiboye</surname><given-names>T.</given-names></name>; <name><surname>Uwazie</surname><given-names>J. N.</given-names></name>; <name><surname>Haliru</surname><given-names>F. Z.</given-names></name>; <name><surname>Ibitoye</surname><given-names>O. B.</given-names></name>; <name><surname>Sunmonu</surname><given-names>T. O.</given-names></name>; <name><surname>Yakubu</surname><given-names>M.</given-names></name>
<article-title>Mechanisms of Action of Columbamine,
Jatrorrhizine
and Magnoflorine as Antidiabetic Agents</article-title>. <source>Recent
Prog. Med. Plants</source>
<year>2017</year>, <volume>45</volume>, <fpage>221</fpage>&#x02013;<lpage>232</lpage>.</mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name><surname>Al-Ishaq</surname><given-names>R. K.</given-names></name>; <name><surname>Abotaleb</surname><given-names>M.</given-names></name>; <name><surname>Kubatka</surname><given-names>P.</given-names></name>; <name><surname>Kajo</surname><given-names>K.</given-names></name>; <name><surname>B&#x000fc;sselberg</surname><given-names>D.</given-names></name>
<article-title>Flavonoids
and Their Anti-Diabetic Effects: Cellular Mechanisms and Effects to
Improve Blood Sugar Levels</article-title>. <source>Biomolecules</source>
<year>2019</year>, <volume>9</volume>, <fpage>430</fpage><pub-id pub-id-type="doi">10.3390/biom9090430</pub-id>.</mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="book" id="cit44"><person-group person-group-type="allauthors"><name><surname>Subramoniam</surname><given-names>A.</given-names></name></person-group><source>Plants with
Anti-Diabetes Mellitus Properties</source>; <publisher-name>CRC Press</publisher-name>: <year>2016</year>.</mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name><surname>Farahmandfar</surname><given-names>R.</given-names></name>; <name><surname>Kenari</surname><given-names>R. E.</given-names></name>; <name><surname>Asnaashari</surname><given-names>M.</given-names></name>; <name><surname>Shahrampour</surname><given-names>D.</given-names></name>; <name><surname>Bakhshandeh</surname><given-names>T.</given-names></name>
<article-title>Bioactive
Compounds, Antioxidant and Antimicrobial
Activities of Arum Maculatum Leaves Extracts as Affected by Various
Solvents and Extraction Methods</article-title>. <source>Food Sci. Nutr.</source>
<year>2019</year>, <volume>7</volume>, <fpage>465</fpage>&#x02013;<lpage>475</lpage>. <pub-id pub-id-type="doi">10.1002/fsn3.815</pub-id>.<pub-id pub-id-type="pmid">30847124</pub-id></mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal" id="cit46"><name><surname>Mukherjee</surname><given-names>P. K.</given-names></name>; <name><surname>Rai</surname><given-names>S.</given-names></name>; <name><surname>Bhattacharya</surname><given-names>S.</given-names></name>; <name><surname>Wahile</surname><given-names>A.</given-names></name>; <name><surname>Saha</surname><given-names>B. P.</given-names></name>
<article-title>Marker Analysis
of Polyherbal Formulation, Triphala - A Well Known Indian Traditional
Medicine</article-title>. <source>Indian J. Tradit. Knowl.</source>
<year>2008</year>, <volume>7</volume>, <fpage>379</fpage>&#x02013;<lpage>383</lpage>.</mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal" id="cit47"><name><surname>Khan</surname><given-names>W.</given-names></name>; <name><surname>Parveen</surname><given-names>R.</given-names></name>; <name><surname>Chester</surname><given-names>K.</given-names></name>; <name><surname>Parveen</surname><given-names>S.</given-names></name>; <name><surname>Ahmad</surname><given-names>S.</given-names></name>
<article-title>Hypoglycemic
Potential of Aqueous Extract of Moringa Oleifera Leaf and in Vivo
GC-MS Metabolomics</article-title>. <source>Front. Pharmacol.</source>
<year>2017</year>, <volume>8</volume>, <fpage>577</fpage><pub-id pub-id-type="doi">10.3389/fphar.2017.00577</pub-id>.<pub-id pub-id-type="pmid">28955221</pub-id></mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal" id="cit48"><name><surname>Parveen</surname><given-names>R.</given-names></name>; <name><surname>Khan</surname><given-names>N.</given-names></name>; <name><surname>Zahiruddin</surname><given-names>S.</given-names></name>; <name><surname>Ibrahim</surname><given-names>M.</given-names></name>; <name><surname>Anjum</surname><given-names>V.</given-names></name>; <name><surname>Parveen</surname><given-names>B.</given-names></name>; <name><surname>Khan</surname><given-names>M. A.</given-names></name>
<article-title>TLC-Bioautographic
Evaluation for
High-Throughput Screening and Identification of Free Radical Scavenging
and Antidiabetic Compounds from Traditional Unani Medicinal Plant:
Citrullus Colocynthis Schrad</article-title>. <source>J. AOAC Int.</source>
<year>2020</year>, <fpage>669</fpage><pub-id pub-id-type="doi">10.5740/jaoacint.19-0287</pub-id>.</mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal" id="cit49"><name><surname>Zahiruddin</surname><given-names>S.</given-names></name>; <name><surname>Khan</surname><given-names>W.</given-names></name>; <name><surname>Nehra</surname><given-names>R.</given-names></name>; <name><surname>Alam</surname><given-names>M. J.</given-names></name>; <name><surname>Mallick</surname><given-names>M. N.</given-names></name>; <name><surname>Parveen</surname><given-names>R.</given-names></name>; <name><surname>Ahmad</surname><given-names>S.</given-names></name>
<article-title>Pharmacokinetics
and Comparative
Metabolic Profiling of Iridoid Enriched Fraction of Picrorhiza Kurroa
&#x02013; An Ayurvedic Herb</article-title>. <source>J. Ethnopharmacol.</source>
<year>2017</year>, <volume>197</volume>, <fpage>157</fpage>&#x02013;<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2016.07.072</pub-id>.<pub-id pub-id-type="pmid">27469200</pub-id></mixed-citation></ref></ref-list></back></article>